AB-201

· GC Cell Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AB-201, covering 2025-01-24 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201 [Phase 1]